Episode Details

hVIVO has reported full-year 2025 results against a tougher market backdrop, while continuing to reposition the business and integrate acquisitions. In this interview, CEO Mo Khan discusses the headline financials, the performance of the core human challenge trial business, the pressures faced during the year, and what investors should be looking for in 2026.